HomeTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Previous close
₹846.65
Day range
₹830.45 - ₹938.80
Year range
₹571.40 - ₹1,055.00
Market cap
47.93B INR
Avg Volume
107.91K
P/E ratio
53.83
Dividend yield
2.02%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.78B | 15.66% |
Operating expense | 517.30M | 38.95% |
Net income | 219.50M | 23.45% |
Net profit margin | 12.30 | 6.68% |
Earnings per share | 4.16 | 17.51% |
EBITDA | 622.15M | 96.71% |
Effective tax rate | 54.08% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.56B | 6.73% |
Total assets | 6.76B | 5.04% |
Total liabilities | 1.39B | 19.78% |
Total equity | 5.37B | — |
Shares outstanding | 53.80M | — |
Price to book | 8.48 | — |
Return on assets | — | — |
Return on capital | 22.81% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 219.50M | 23.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,693
